Connect with us

Legal & Regulation

Senator Cory Booker Will Only Support Marijuana Bills Which Back Restorative Justice

Published

on

Senator Cory Booker Will Only Support Marijuana Bills Which Back Restorative Justice

Marijuana banking issues are up for discussion in the House and Senator Cory Booker stated that he will not support any cannabis legislation that does not include restorative justice. This statement comes at a crucial time as the House announced that the first floor vote would be cannabis reform legislation. This is a bill to protect banks that service cannabis businesses. This development is also controversial as several advocacy groups argue that a vote should be delayed until further legislation is passed.

The statement comes at a critical moment in the marijuana reform movement. House leadership announced on Friday that the first full floor vote on a standalone piece of cannabis reform legislation—a bill to protect banks that service cannabis businesses from being penalized by federal regulators—will be held next week. But that development has also created controversy, with several advocacy groups arguing that a vote should be postponed until more wide-ranging reform legislation is passed.

Although Booker didn’t directly reference the banking bill his tweet, its timing seemed to suggest that he sides with those groups—which include the ACLU, Human Rights Watch and Drug Policy Alliance—and that he wouldn’t support the Secure and Fair Enforcement (SAFE) Banking Act as written. Marijuana Moment reached out to his office for clarification, but a representative was not immediately available.

While some have made the case that the bill would help promote social equity by improving access to banking services for minority business owners, others view the legislation as primarily benefiting large cannabis firms. The senator has focused on the need for inclusive and comprehensive marijuana reform. He claims that the initial bill didn’t meet his standard and he did not want to attach his name to it. He believes that it is unfair to push forward something that doesn’t do any restorative justice. He wants justice done to communities that have suffered as a result of marijuana prohibition.

He stated that,

“I get very angry when people talk about legalizing marijuana and then give no light to how marijuana law enforcement was done in ways that fed upon poor communities—black and brown communities. This is a war on drugs that has not been a war on drugs—it’s been a war on people, and disproportionately poor people and disproportionately black and brown people.”

He wishes that legalization be paired with expunging prior cannabis convictions. The difficulty is that legalization already face an uphill battle with anti-marijuana opposition and skepticism from lawmakers.

Abby Veronika is one of the leading researchers here and resides in Southern California where she is a student at a local college to study Communications. While she is a best-selling women’s romance novel author on Amazon, her real expertise and passion lives within the cannabis, health and nutrition space.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.